In a groundbreaking development, Wockhardt Hospital, Mumbai Central, has showcased the transformative potential of robotics in orthopedic surgery through the remarkable journey of Mrs. Reema, a patient grappling with end-stage arthritis and a complex orthopedic dilemma.

Mrs. Reema’s story serves as a beacon of hope for patients facing similar challenges, as she navigated her way to renewed mobility and comfort with the aid of cutting-edge technology and compassionate care.

Under the expert guidance of Dr. Manan Shah, Consultant Joint Replacement surgeon at Wockhardt Hospitals Mumbai Central, Mrs. Reema underwent a two-phase surgical intervention tailored to her unique circumstances.

The first phase involved a conventional knee replacement on Mrs. Reema’s left side, facilitating her recovery and paving the way for the subsequent phase.

In the second phase, Dr. Shah introduced the revolutionary Stryker Mako robot, which enabled a knee replacement surgery on Mrs. Reema’s right side without the need to remove a previously embedded rod. This state-of-the-art robotic system exhibited unparalleled precision, allowing Dr. Shah and his team to navigate Mrs. Reema’s anatomy with unmatched accuracy, ensuring a personalized and optimized outcome.

The decision to incorporate robotic assistance not only spared Mrs. Reema from the ordeal of unnecessary surgery but also exemplified a commitment to leveraging technology for enhancing patient outcomes and quality of life.

In the aftermath of this innovative approach, Mrs. Reema has emerged triumphant, seamlessly reintegrating into her routine life free from the shackles of debilitating knee pain.

This remarkable feat underscores Wockhardt Hospital, Mumbai Central’s dedication to embracing advancements that redefine the landscape of orthopedic care, offering renewed hope and possibilities for patients worldwide.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.